Pharmaceutical agent having long-lasting effect of treating arthritic disorders
    1.
    发明授权
    Pharmaceutical agent having long-lasting effect of treating arthritic disorders 有权
    具有治疗关节炎疾病长期作用的药剂

    公开(公告)号:US08889652B2

    公开(公告)日:2014-11-18

    申请号:US12448064

    申请日:2007-12-06

    摘要: The present invention relates to an injection solution for intra-articular administration for treating arthritic disorders comprising a cross-linked hyaluronic acid derivative wherein part of functional groups of a hyaluronic acid are cross-linked with a cross-linking group to the extent of 0.6 to 15% of cross-linking extent as an active ingredient in an amount having a long-lasting analgesic effect and a pharmaceutically acceptable carrier, and an analgesic composition for suppressing a cartilage degeneration caused by arthritic disorders or a composition for suppressing a cartilage degeneration or an inflammation of synovium caused by arthritic disorders each comprising the cross-linked hyaluronic acid derivative and a pharmaceutically acceptable carrier.

    摘要翻译: 本发明涉及用于治疗关节炎疾病的关节内给药的注射液,其包含交联的透明质酸衍生物,其中透明质酸的官能团的一部分与交联基团交联至0.6〜 具有持久镇痛效果的量的作为活性成分的交联程度的15%和药学上可接受的载体,以及用于抑制由关节炎病症引起的软骨退化的镇痛组合物或用于抑制软骨退化的组合物或 由关节炎病症引起的滑膜的炎症各自包含交联的透明质酸衍生物和药学上可接受的载体。

    Nucleus Pulposus Filler
    2.
    发明申请
    Nucleus Pulposus Filler 审中-公开
    核筋膜填料

    公开(公告)号:US20080249062A1

    公开(公告)日:2008-10-09

    申请号:US11579673

    申请日:2005-04-28

    IPC分类号: A61K31/737

    摘要: The present invention provides a nucleus pulposus filler or the like which is to be packed into an area in deformed intervertebral disc wherein normal nucleus should be located and can be stabley maintained for a long time. More preferably, the present invention provides a nucleus pulposus filler comprising a crosslinked chondroitin sulfate as an active ingredient. The photocrosslinked chondroitin sulfate is preferably the following one: a photocrosslinked chondroitin sulfate obtainable by freezing a photoreactive chondroitin sulfate-containing solution comprising: a photoreactive chondroitin sulfate to which a photoreactive group is bound; an aqueous solvent capable of dissolving the photoreactive chondroitin sulfate; and any one substance selected from the group consisting of an alcohol having aqueous solvent miscibility, a surfactant, and a cheleting agent; irradiating the resulting frozen product with light; and then melting the frozen product. The filler can be provided as a kit by packing it into a container from which the filler can be pushed out.

    摘要翻译: 本发明提供一种髓核填充物等,其将被包装在变形椎间盘的区域中,其中应当定位正常的核并且可以长期稳定地保持。 更优选地,本发明提供了包含交联的硫酸软骨素作为活性成分的髓核填充物。 光交联的硫酸软骨素优选如下:通过冷冻含有光反应性硫酸软骨素溶液的光交联的软骨素硫酸盐,其包含:光反应性硫酸软骨素结合的光反应性硫酸软骨素; 能够溶解光反应性硫酸软骨素的水性溶剂; 和选自具有水溶剂混溶性的醇,表面活性剂和螯合剂的任何一种物质; 用光照射所得冷冻产品; 然后熔化冷冻产品。 填料可以通过将其包装到容器中作为试剂盒提供,填料可从该容器中推出。

    Remedies for bladder disorders
    3.
    发明授权
    Remedies for bladder disorders 有权
    膀胱功能障碍

    公开(公告)号:US06232301B1

    公开(公告)日:2001-05-15

    申请号:US09142032

    申请日:1998-08-27

    IPC分类号: A61K3170

    CPC分类号: A61K31/715 A61K9/0034

    摘要: In order to provide an agent for treatment of bladder troubles that has vesical mucosa epithelium dilatation promoting action and/or vesical mucosa healing action, and exhibits excellent curative effect for bladder troubles, in particular, non-bacterial intractable bladder troubles, the agent for treatment of bladder troubles is formulated with hyaluronic acid and/or a pharmaceutically acceptable salt thereof, preferably hyaluronic acid and/or a pharmaceutically acceptable salt thereof having the following physicochemical properties: (A) endotoxin content; 0.03 EU (endotoxin unit)/10 mg or less, (B) sulfur content; 0.01% or less as determined by coulometric titration, (C) iron content; 20 ppm or less, (D) protein content; 0.1% or less, and (E) weight average molecular weight; 500,000 or more, in an amount effective for promoting vesical mucosa epithelium dilatation and/or healing vesical mucosa, preferably in an amount of 0.2-0.6% by weight based on total amount of the agent.

    摘要翻译: 为了提供具有膀胱粘膜上皮扩张促进作用和/或膀胱粘膜愈合作用的膀胱麻烦的治疗剂,对膀胱麻烦,特别是非细菌难治性膀胱麻烦,治疗剂 膀胱麻烦的透明质酸和/或其药学上可接受的盐,优选透明质酸和/或其药学上可接受的盐,具有以下物理化学性质:(A)内毒素含量; 0.03欧盟(内毒素单位)/ 10毫克或更少,(B)硫含量; 0.01%以下,通过库仑滴定测定,(C)铁含量; 20ppm以下,(D)蛋白质含量; 0.1%以下,(E)重均分子量; 500,000或更多,其量有效促进膀胱粘膜上皮扩张和/或愈合膀胱粘膜,优选为基于试剂总量的0.2-0.6重量%。

    Sheet folding processing apparatus and image forming system including the same

    公开(公告)号:US11066269B2

    公开(公告)日:2021-07-20

    申请号:US16843227

    申请日:2020-04-08

    申请人: Katsuya Takahashi

    发明人: Katsuya Takahashi

    IPC分类号: B65H45/20 B65H45/14 B65H45/04

    摘要: A sheet folding processing apparatus suppresses an increase in size and cost of the apparatus and performs folding processing on continuously conveyed sheets. In the sheet folding processing apparatus, a sheet conveyed by a feeding roller pair and hang in a loop shape in a loop forming space is pushed into a nipping portion of a folding roller pair by a pushing plate, so that the sheet is folded in a Z-shape to form a plurality of fold lines. The sheet is conveyed in the conveyance direction until the sheet rear end passes through the feeding roller pair, and after the sheet rear end is stored in a loop forming space by moving the pushing plate from a position for pushing the sheet into a nipping portion to a retracting position, the reinforcing processing of the fold line of the sheet is performed by an additional folding unit.

    Transmisssion/reception system, transmitting device and method, and receiving device and method
    7.
    发明申请
    Transmisssion/reception system, transmitting device and method, and receiving device and method 审中-公开
    转移/接收系统,发送装置和方法,以及接收装置和方法

    公开(公告)号:US20060245428A1

    公开(公告)日:2006-11-02

    申请号:US10547212

    申请日:2004-02-19

    IPC分类号: H04L12/56

    摘要: The present invention relates to a transmitter and a receiver designed to improve the reliability of communications therebetween. During communication processes under UDP adopted as the transport layer, data having RTP headers is transmitted and received between the transmitter and the receiver. The receiver references the sequence numbers in the received RTP headers to verify the continuity of the numbers. If any data with a serially continuous sequence number is not received, the receiver finds that data to be missing and requests the transmitter to retransmit the data associated with the missing sequence number. The receiver then acquires the missing data that has been retransmitted. This invention applies to transmitters that transmit data and to receivers that receive the transmitted data.

    摘要翻译: 本发明涉及一种设计用于提高其间通信的可靠性的发射机和接收机。 在采用UDP作为传输层的通信过程中,在发射机和接收机之间发送和接收具有RTP头的数据。 接收机引用接收的RTP报头中的序列号来验证数字的连续性。 如果没有接收到具有连续序列号的任何数据,则接收机发现数据丢失,并请求发送器重传与丢失序列号相关联的数据。 然后,接收器获取已重传的丢失数据。 本发明适用于发送数据的发送机和接收发送数据的接收机。